In the wake of Portugal's pivotal shift to animal welfare legislation in 2018, where the no-kill policy for population control came into effect, animal shelters have emerged as critical sanctuaries for stray or unwanted animals. Recognising the critical role that adopter preferences play in the successful placement of shelter animals and the pressing need for shelters to expedite adoptions to liberate valuable space to accommodate more animals in need of refuge, this study seeks to investigate the intricate matrix of factors guiding adopters' choices. A descriptive cross-sectional study was performed with a convenience sample of the Portuguese population to assess their preferences and opinions about pet adoption. An online questionnaire was completed by 415 participants from February to October 2021. Among participants selecting attributes for pet adoption, the top preferences were behaviour (52.8%), size (49.6%), vaccination and deworming status (44.3%), and age (36.1%). Conversely, breed (7.2%), sex (6.3%), and animal colour (5.1%) were the least prioritised. Combinations were established based on the most selected attributes. Certain participant characteristics, such as education level and pet ownership history, exhibited distinct preferences in animal attributes. Portuguese people show a marked preference for shelter adoption, prioritising behaviour, size, and health over breed and colour. This insight allows shelters to allocate resources effectively. While promising, the trend towards shelter adoption needs adaptive strategies to align with evolving adopter preferences.

Canine leishmaniosis (CanL) is a chronic, systemic and often severe disease. The main causative agent of CanL is a protozoan parasite, Leishmania infantum, with phlebotomine sand flies acting as vectors. In Europe and other continents, L. infantum is also responsible for leishmaniosis in other animals, such as cats, horses and humans. In Portugal, animal and human leishmanioses are endemic, and high prevalence levels of infection and disease have been reported in dogs. There is a prejudice against stray animals and also those housed in shelters, assuming they have higher levels of infection with vector-borne pathogens, including L. infantum, when compared to domestic animals. In north-eastern Portugal, serum samples were obtained from March to May 2022 in three shelters (n = 179) and 13 veterinary clinics (n = 164), resulting in 343 dogs being analysed for antibodies to Leishmania spp. by the direct agglutination test (DAT). The overall seroprevalence was 9.9%, with 15.2% seroprevalence in domestic dogs and 5.0% in the shelter ones (p = 0.003). The fact that shelter dogs had a lower seroprevalence could be explained by more regular veterinary care provided in shelters regarding preventive measures, including insecticides with an antifeeding effect, in comparison with domestic dogs.

A cross-sectional study was conducted to gain insight into the epidemiology of canine ehrlichiosis and rickettsiosis in northern Portugal. Specific IgG antibodies to Ehrlichia canis were analysed using a commercial indirect ELISA test, and antibodies to Rickettsia conorii using a commercial IFAT. A total of 113 dogs from two different shelters were sampled, and seroprevalence values of 0.9% (95% confidence [CI]: 0.2–4.8%) for E. canis and 9.7 (95% CI: 5.5–16.6%) for R. conorii were found. Univariable models investigated risk factors for seropositivity. The odds ratios (OR) of R. conorii seropositivity were higher for female dogs (OR = 2.32; 95% CI: 1.58–3.39) and for dogs belonging to Shelter 2 (OR = 3.0; 95% CI: 2.28–3.95). Seropositive dogs for co-infection (E. canis + R. conorii) were more frequently observed in females (OR = 2.4; CI 95%: 1.66–3.47) and in Shelter 2 (OR = 2.72; 95% CI: 1.97–3.76). These findings show that shelter dogs in northern Portugal are exposed to E. canis and R. conorii, which can affect both canines and humans. It is imperative to adopt a One Health approach to educate the public about the hazards of canine zoonoses and develop legislation and procedures to control their spread and preserve public health.

In Brazil, the production of corn and soybeans has been growing significantly in recent years. Considering that the strategies for investing in the production of these crops are conditioned by production costs and risk, the objective of this article is to propose a simulation model that indicates the trend of production costs for these commodities, considering the dispersion and correlation of selected key variable prices and corn and soybean production costs practiced between the years of 2018 and 2022. Fifty specialized companies in the state of Sao Paulo, Brazil, provided data for this study, and Monte Carlo simulations showed that the total cost of corn production/ha is between USD 600.00 and USD 1150.00, with a level of certainty of 84.7%, and soybeans are in the range of USD 260.00 to USD 420.00, with a level of certainty of 86.4%. The model evidenced a trend of decreasing production costs for the crops for the 2023/24 and 2024/25 harvests, as the input with the greatest impact (fertilizer) is showing a downward trend. On the other hand, costs related to labor, soybean seed, and fungicides are showing an upward trend, while dolomitic limestone corrective remains stable.

The late diagnosis of Type 2 Diabetes Mellitus can occur due to lack of access to the primary health care system and the non-manifestation of symptoms. Faced with this problem, this work presents the creation of a mobile application, called DiabetesCheck, for predicting the risk of Type 2 Diabetes Mellitus. A mathematical model is used, which classifies the risk of Type 2 Diabetes Mellitus for a group of patients with intervention and for a comparative group, using Fuzzy Classification and Decision Trees. The proposed application allows the health professional to monitor patients through the history stored in a database, allowing a representation of the evolution of patients and indication of medications. Therefore, this proposal aims to carry out the diagnosis in the initial phase of the disease and help in the prescription of more effective treatments and in the proposition of public policy strategies in epidemiology and screening.